Item 1.01 Entry into a Material Definitive Agreement.

On December 21, 2012, Bio-Reference Laboratories, Inc. (the "Company") entered into an agreement with Meridian Clinical Laboratory Corporation, a Florida corporation having its place of business in Miami, Florida ("Meridian"), pursuant to which the Company purchased all issued and outstanding common stock of Meridian for approximately $1,850,000, of which $250,000 is deferred for one year. $1,600,000 was paid in cash.

Meridian was established in the year 2000 and had assets of $401,376 as of June 30, 2012.

Meridian is a privately held, independent medical testing laboratory specializing in bacteriology, chemistry, diagnostic immunology, hematology, and mycology.

The stock purchase transaction is described in more detail in the annexed Stock Purchase Agreement (Exhibit 1.1).

The foregoing description is only a summary and is qualified in its entirety by reference to the Stock Purchase Agreement, which is incorporated by reference into this Item 1.01.

---